Researchers should anticipate and track adverse effects in psychedelics research, a group of Maryland-based scientists argue in a paper recently published in Psychedelic Medicine.
For years, the field has been focused on the potential benefits of psychedelics, but the scientists argue that it’s time to pay more attention to understanding the risks.